CD4 and neoplasm: Tumor infiltrating lymphocytes (TILs), commonly recognized as an immunological parameter and a morphological manifestation of anticancer immune response, represent a major infiltrating immune cell subpopulation, which consist of CD3+, CD4+, and CD8+ TILs.